ARCHIVES

Isis 3521 Gets Fast-track Status For FDA Review.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort

November 24, 1995

NCI Plans Conference On DES Late Effects, Reproductive Cancers

November 29, 1991

Task Force Urges HHS to Form Committee To Implement Genetic Testing Regulations

November 7, 1997

NIH Establishes Women’s Health Office, Responds To Criticism

September 14, 1990

NCAB Approves Call For New Efforts In Black/Hispanic Cancer

February 6, 1981

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

March 5, 1993